Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.
作者信息
Lagunas-Rangel Francisco Alejandro
机构信息
Department of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), Mexico City, Mexico.
出版信息
J Med Virol. 2020 Oct;92(10):1733-1734. doi: 10.1002/jmv.25819. Epub 2020 Apr 8.
Abstract
摘要
相似文献
1
Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.2019年冠状病毒病（COVID-19）重症患者的中性粒细胞与淋巴细胞比值及淋巴细胞与C反应蛋白比值：一项荟萃分析。
J Med Virol. 2020 Oct;92(10):1733-1734. doi: 10.1002/jmv.25819. Epub 2020 Apr 8.
2
C-reactive protein and neutrophil-lymphocyte ratio as predictors of mortality in coronavirus disease 2019.C 反应蛋白和中性粒细胞与淋巴细胞比值可预测 2019 年冠状病毒病患者的死亡率。
Rev Assoc Med Bras (1992). 2021 Oct;67(10):1498-1502. doi: 10.1590/1806-9282.20210679.
3
Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.亚洲人群中重症与非重症 COVID-19 患者的实验室特征：系统评价和荟萃分析。
Eur J Med Res. 2020 Aug 3;25(1):30. doi: 10.1186/s40001-020-00432-3.
4
Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross-sectional study.中性粒细胞与淋巴细胞比值作为 2019 冠状病毒病患者的预后和预测因素：一项回顾性横断面研究。
J Med Virol. 2020 Nov;92(11):2573-2581. doi: 10.1002/jmv.26061. Epub 2020 Jun 9.
5
Associations of procalcitonin, C-reaction protein and neutrophil-to-lymphocyte ratio with mortality in hospitalized COVID-19 patients in China.降钙素原、C 反应蛋白和中性粒细胞与淋巴细胞比值与中国住院 COVID-19 患者死亡率的关系。
Sci Rep. 2020 Sep 14;10(1):15058. doi: 10.1038/s41598-020-72164-7.
6
Moderate vs. mild cases of overseas-imported COVID-19 in Beijing: a retrospective cohort study.北京境外输入新型冠状病毒肺炎轻症与中症病例的回顾性队列研究
Sci Rep. 2021 Mar 22;11(1):6483. doi: 10.1038/s41598-021-85869-0.
7
Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity.循环无细胞 DNA、外周血淋巴细胞亚群改变和中性粒细胞与淋巴细胞比值在评估 COVID-19 严重程度中的作用。
Innate Immun. 2021 Apr;27(3):240-250. doi: 10.1177/1753425921995577. Epub 2021 Mar 1.
8
Comparison of Blood Counts and Markers of Inflammation and Coagulation in Patients With and Without COVID-19 Presenting to the Emergency Department in Seattle, WA.比较华盛顿州西雅图急诊就诊的 COVID-19 患者与非 COVID-19 患者的血液计数及炎症和凝血标志物。
Am J Clin Pathol. 2021 Jul 6;156(2):185-197. doi: 10.1093/ajcp/aqab052.
9
A systematic review and meta-analysis of the association between the neutrophil, lymphocyte, and platelet count, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio and COVID-19 progression and mortality.中性粒细胞、淋巴细胞和血小板计数、中性粒细胞与淋巴细胞比值以及血小板与淋巴细胞比值与新型冠状病毒肺炎进展和死亡率之间关联的系统评价与荟萃分析。
Expert Rev Clin Immunol. 2022 Nov;18(11):1187-1202. doi: 10.1080/1744666X.2022.2120472. Epub 2022 Sep 5.
10
High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients.高中性粒细胞与淋巴细胞比值作为COVID-19患者的预后标志物
Clin Nutr ESPEN. 2020 Dec;40:101-102. doi: 10.1016/j.clnesp.2020.08.004. Epub 2020 Aug 14.
引用本文的文献
1
Comparative effectiveness of anti-inflammatory and antiviral therapies on NLR and survival outcomes in severe COVID-19: multicenter retrospective study.抗炎和抗病毒疗法对重症 COVID-19 患者中性粒细胞与淋巴细胞比值及生存结局的比较有效性：多中心回顾性研究
PeerJ. 2025 Sep 4;13:e20003. doi: 10.7717/peerj.20003. eCollection 2025.
2
Association between complete blood count-derived inflammatory biomarkers and renal failure: a cross-sectional study from NHANES 2007-2020.全血细胞计数衍生的炎症生物标志物与肾衰竭之间的关联：一项来自2007 - 2020年美国国家健康与营养检查调查（NHANES）的横断面研究。
BMJ Open. 2025 Sep 1;15(9):e103381. doi: 10.1136/bmjopen-2025-103381.
3
Assessment of Mortality Risk in Patients With Community-Acquired Pneumonia: Role of Novel Inflammatory Biomarkers.社区获得性肺炎患者死亡风险评估：新型炎症生物标志物的作用
J Clin Lab Anal. 2025 Sep;39(17):e70081. doi: 10.1002/jcla.70081. Epub 2025 Aug 13.
4
Difference in Lymphocyte Subset Counts According to Disease Severity and SARS-CoV-2 Variants of Hospitalized COVID-19 Patients in Korea.韩国住院COVID-19患者淋巴细胞亚群计数根据疾病严重程度和SARS-CoV-2变异株的差异
J Korean Med Sci. 2025 Jul 28;40(29):e172. doi: 10.3346/jkms.2025.40.e172.
5
Cytoimmunological Profile of Lower Airways in Post-COVID-19 Syndrome (PCS): Predictive Value of Bronchoalveolar Lavage.新冠后综合征（PCS）下呼吸道的细胞免疫特征：支气管肺泡灌洗的预测价值
J Clin Med. 2025 May 12;14(10):3361. doi: 10.3390/jcm14103361.
6
The Effect of Fungal Nutraceutical Supplementation on Postoperative Complications, Inflammatory Factors and Fecal Microbiota in Patients Undergoing Colorectal Cancer Surgery with Curative Intent: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial.真菌营养补充剂对接受根治性结直肠癌手术患者术后并发症、炎症因子及粪便微生物群的影响：一项随机、安慰剂对照、双盲临床试验
Biomedicines. 2025 May 13;13(5):1185. doi: 10.3390/biomedicines13051185.
7
Effective new predictors of prognosis and comparison of multidisciplinary treatment options in acute mesenteric ischemia.急性肠系膜缺血预后的有效新预测指标及多学科治疗方案比较
North Clin Istanb. 2025 Apr 28;12(2):162-172. doi: 10.14744/nci.2023.82231. eCollection 2025.
8
The role of C-reactive protein to lymphocyte ratio in NAFLD and mortality among NAFLD patients.C反应蛋白与淋巴细胞比值在非酒精性脂肪性肝病及非酒精性脂肪性肝病患者死亡率中的作用。
BMC Gastroenterol. 2025 May 1;25(1):327. doi: 10.1186/s12876-025-03924-w.
9
Genetic Predictors of Paxlovid Treatment Response: The Role of IFNAR2, OAS1, OAS3, and ACE2 in COVID-19 Clinical Course.帕罗韦德治疗反应的基因预测指标：IFNAR2、OAS1、OAS3和ACE2在新冠临床病程中的作用
J Pers Med. 2025 Apr 17;15(4):156. doi: 10.3390/jpm15040156.
10
Advances in Understanding Inflammation and Tissue Damage: Markers of Persistent Sequelae in COVID-19 Patients.炎症与组织损伤认识的进展：COVID-19患者持续性后遗症的标志物
J Clin Med. 2025 Feb 22;14(5):1475. doi: 10.3390/jcm14051475.
本文引用的文献
1
Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer.淋巴细胞- C 反应蛋白比值作为预测结直肠癌手术和肿瘤学结局的有前途的新标志物。
Ann Surg. 2020 Aug;272(2):342-351. doi: 10.1097/SLA.0000000000003239.
2
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.严重 COVID-19 患者临床实验室数据测定的诊断效用。
J Med Virol. 2020 Jul;92(7):791-796. doi: 10.1002/jmv.25770. Epub 2020 Apr 10.
3
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China.中国武汉 69 例 2019 年冠状病毒病患者的临床特征。
Clin Infect Dis. 2020 Jul 28;71(15):769-777. doi: 10.1093/cid/ciaa272.
4
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病（COVID-19）患者免疫反应失调。
Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.
5
The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia.与严重和危重新冠肺炎相关的临床和胸部 CT 特征。
Invest Radiol. 2020 Jun;55(6):327-331. doi: 10.1097/RLI.0000000000000672.
6
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.中国武汉 140 名 SARS-CoV-2 感染患者的临床特征。
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
7
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
8
Neutrophils and neutrophil-lymphocyte ratio: Inflammatory markers associated with intimal-media thickness of atherosclerosis.中性粒细胞和中性粒细胞与淋巴细胞比值：与动脉粥样硬化内膜中层厚度相关的炎症标志物。
Thromb Res. 2018 Oct;170:45-52. doi: 10.1016/j.thromres.2018.08.002. Epub 2018 Aug 3.
9
Estimating the mean and variance from the median, range, and the size of a sample.根据中位数、极差和样本量估计均值和方差。
BMC Med Res Methodol. 2005 Apr 20;5:13. doi: 10.1186/1471-2288-5-13.
Zotero 插件